Lunaphore: Funding, Investors & Team (Sep 2026)
Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.
Lunaphore has raised $2.1M across 1 funding round on record, the most recent an undisclosed round of $2.1M announced in Apr 2020.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Lunaphore Company Profile and Key Stats
Latest funding round on record: Apr 2020.
Lunaphore Funding Rounds
Lunaphore Founders and Leadership Team
No contact details are on record for this team yet.
Lunaphore Funding Compared to Other Health Care Startups
Lunaphore's latest round of $2.1M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lunaphore in Health Care and Lausanne
Companies Similar to Lunaphore
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Lunaphore Funding FAQs
What does Lunaphore do?
Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.
How much funding has Lunaphore raised?
Lunaphore has raised $2.1M across 1 round on record. The most recent is an undisclosed round of $2.1M announced in Apr 2020.
When did Lunaphore last raise funding?
Lunaphore's most recent funding round on record is an undisclosed round of $2.1M, announced in Apr 2020.
Who is the CEO of Lunaphore?
Ata Tuna Ciftlik is listed as CEO at Lunaphore.
Where is Lunaphore headquartered?
Lunaphore is based in Lausanne, Vaud, Switzerland.
How many employees does Lunaphore have?
Lunaphore is in the 51-100 employee band.
How does Lunaphore's funding compare to other Health Care startups?
Lunaphore's latest round of $2.1M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Lunaphore Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lunaphore is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.